Amgen's Blockbuster Osteoporosis Drug Prolia Flagged With FD

Amgen's Blockbuster Osteoporosis Drug Prolia Flagged With FDA Strictest Warning - Amgen (NASDAQ:AMGN)

FDA issues serious warning on Amgen's Prolia drug, highlighting increased risk of low calcium levels in specific patient groups.

Related Keywords

Amgen Xgeva , Reuters , Amgen Inc , Merck Co Inc , Full Approval For Amgen ,

© 2025 Vimarsana